Nuvectis Pharma, Inc. - COM (NVCT)

Historical Holders from Q1 2022 to Q4 2025

Symbol
NVCT on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3,694,801
Holdings value
$22,240,671
% of all portfolios
0%
Number of holders
52
Number of buys
21
Number of sells
19
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025 Nuvectis Pharma, Inc. - COM (NVCT) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,694,801 shares of the company stock as of 30 Sep 2025.

Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 389,796 $2,942,960 +$296,315 $7.55 2
2025 Q3 3,694,801 $22,240,671 +$875,366 $6.02 52
2025 Q2 3,242,656 $24,212,274 +$8,414,994 $7.47 46
2025 Q1 2,047,125 $20,049,463 +$7,527,325 $9.77 33
2024 Q4 1,320,778 $7,145,290 +$1,393,789 $5.41 31
2024 Q3 1,049,389 $6,599,330 -$770,810 $6.29 31
2024 Q2 1,205,011 $7,627,293 -$2,444,937 $6.33 39
2024 Q1 1,561,977 $12,807,243 +$243,627 $8.20 40
2023 Q4 1,513,319 $12,620,326 +$1,724,001 $8.34 36
2023 Q3 1,277,304 $16,463,186 +$85,912 $12.89 33
2023 Q2 1,252,927 $20,033,198 +$12,444,224 $15.97 37
2023 Q1 483,928 $6,343,634 -$3,188,708 $13.11 13
2022 Q4 983,925 $7,378,970 +$971,414 $7.50 11
2022 Q3 1,416,783 $10,045,000 +$5,343,932 $7.09 8
2022 Q2 642,952 $7,200,000 +$371,552 $11.20 9
2022 Q1 628,110 $4,654,000 +$4,653,995 $7.40 7